Abstract

This review overviews the impact in biomedicine of surface enhanced. Raman scattering motivated by the great potential we believe this technique has. We present the advantages and limitations of this technique relevant to bioanalysis in vitro and in vivo and how this technique goes beyond the state of the art of traditional analytical, labelling and healthcare diagnostic technologies.

Keywords: Biomedicine, bioanalytes, Surface-enhanced Raman Scattering (SERS), nanoparticles, hybrid plasmonic platforms, biosensors, multiplexed bioanalysis, early diagnosis.